Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of AZD2373, an antisense oligonucleotide targeting APOL1

被引：0

作者：

Greasley, Peter J. ^{[1
]}

Agrawal, Nikhil ^{[2
]}

Althage, Magnus ^{[3
]}

Sanchez, Jose ^{[4
]}

Kirk, Sarah ^{[5
]}

Egeland, Erlend Johannessen ^{[6
]}

Astrand, Magnus ^{[6
]}

Westergren, Helena ^{[7
]}

Sherwood, James ^{[8
]}

Mccarthy, Michael ^{[9
]}

Patel, Uptal ^{[2
]}

Macphee, Iain ^{[10
]}

机构：

[1] BioPharmaceut R&D, Early Clin Dev, Cardiovasc Renal & Metab, Res & Early Dev, Gothenburg, Sweden

[2] BioPharmaceut R&D, Res & Early Dev, Cardiovasc Renal & Metab, Early Clin Dev, Gaithersburg, MD USA

[3] BioPharmaceut R&D, Translat Sci & Expt Med, Early Cardiovasc Renal & Metab, Gothenburg, Sweden

[4] AstraZeneca, Early Biometr Stat Innovat, Data Sci & Artificial Intelligence R&D, Gothenburg, Sweden

[5] AstraZeneca, Data Sci & Artificial Intelligence R&D, Early Biometr Stat Innovat, Cambridge, England

[6] AstraZeneca, Clin Pharmacol & Quantitat Pharmacol, Clin Pharmacol & Safety Sci R&D, Gothenburg, Sweden

[7] AstraZeneca, Precis Med & Biosamples Biopharmaceut, Precis Med & Biosamples Oncol R&D, Gothenburg, Sweden

[8] AstraZeneca, Precis Med & Biosamples Biopharmaceut, Precis Med & Biosamples Oncol R&D, Cambridge, England

[9] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Projects Res & Early Dev,Res & Early Dev, Gaithersburg, MD USA

[10] AstraZeneca, BioPharmaceut R&D, Early Clin Dev, Res & Early Dev,Cardiovasc Renal & Metab, Cambridge, England

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

1003

引用

页码：I1134 / I1135

页数：2

共 50 条

[1] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of AZD2373, an antisense oligonucleotide targeting APOL1
Greasley, Peter J.
Agrawal, Nikhil
Althage, Magnus
Sanchez, Jose
Kirk, Sarah
Egeland, Erlend Johannessen
Astrand, Magnus
Westergren, Helena
Sherwood, James
Mccarthy, Michael
Patel, Uptal
Macphee, Iain
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
[2] Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
Butler, Kathleen
Teng, Renli
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (01) : 65 - 77
[3] Safety, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD8233, Targeting PCSK9, in Patients with Dyslipidemia
Hofherr, Alexis
Nilsson, Catarina A.
Rekic, Dinko
Knoechel, Jane
Goldwater, Ronald
Han, David
Kusnir, Jorge
Overcash, J. Scott
Waters, Michael
White, Alexander
Hurt-Camejo, Eva
CIRCULATION, 2021, 144
[4] Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Naloxegol
Eldon, Michael A.
Kugler, Alan R.
Medve, Robert A.
Bui, Khanh
Butler, Kathleen
Sostek, Mark
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (06): : 442 - 448
[5] Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
He, Xuemei
Gao, Xin
Xie, Panpan
Liu, Yuan
Bai, Wenjing
Liu, Yue
Shi, Aixin
DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2967 - 2980
[6] Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of TAK-935 in Healthy Subjects
Wang, Shining
Chen, Grace
Uz, Tolga
Affinito, John
NEUROLOGY, 2018, 90
[7] Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of AZD7594 after single and multiple ascending inhaled doses in healthy Japanese males
Chen, Yingxue
Su, Hong-Lin
Brown, Mary
Bjersing, Mats
Steele, John
Aggarwal, Ajay
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[8] Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects
Patat, Alain
Parks, Virginia
Raje, Sangeeta
Plotka, Anna
Chassard, Didier
Le Coz, F.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (03) : 299 - 308
[9] SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF AZD7594 AFTER SINGLE AND MULTIPLE ASCENDING INHALED DOSES IN HEALTHY MALE VOLUNTEERS.
Chen, Y.
Prothon, S.
Aurivillius, M.
Eriksson, U. G.
Aggarwal, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S39 - S39
[10] Safety, tolerability and pharmacokinetics of single ascending doses of ALG-020572, a GalNAc-conjugated antisense oligonucleotide, in healthy subjects
Gane, Edward J.
Yuen, Man-Fung
Schwabe, Christian
Wu, Min
Le, Kha
Rito, Jen
Gupta, Kusum
Westland, Christopher
Lai, Felix
Venkatraman, Meenakshi
Fitzgerald, Megan
Lin, Tse-I
Blatt, Lawrence
Chanda, Sushmita
McClure, Matt
Fry, John
Agarwal, Kosh
JOURNAL OF HEPATOLOGY, 2022, 77 : S824 - S824

← 1 2 3 4 5 →